EBV Type 1 versus Type 2: A determinant of NK cell anti-tumor activity in Burkitt lymphoma.
Saved in:
| Title: | EBV Type 1 versus Type 2: A determinant of NK cell anti-tumor activity in Burkitt lymphoma. |
|---|---|
| Authors: | Forconi CS; Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester MA, USA., Shumate L; Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester MA, USA., Racenet Z; Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester MA, USA., M'Bana V; Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester MA, USA., Oduor C; Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, USA., Matta A; Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester MA, USA., Melo J; Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester MA, USA., Oluoch PO; Department of Microbiology, University of Massachusetts Chan Medical School, Worcester MA, USA., Odwar B; Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Otieno J; Jaramogi Oginga Odinga Teaching and Referral Hospital, Kisumu, Kenya., Vik TA; Department of Pediatrics, Hematology/Oncology, Indiana University School of Medicine, Indianapolis, Indiana, USA., N'juguna F; Department of Child Health and Paediatrics, Moi University, Eldoret, Kenya., Kinyua AW; Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Bailey JA; Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, USA., Münz C; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland., Moormann AM; Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester MA, USA. |
| Source: | BioRxiv : the preprint server for biology [bioRxiv] 2026 Feb 10. Date of Electronic Publication: 2026 Feb 10. |
| Publication Type: | Journal Article; Preprint |
| Journal Info: | Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41727163 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: EBV Type 1 versus Type 2: A determinant of NK cell anti-tumor activity in Burkitt lymphoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Forconi+CS%22">Forconi CS</searchLink>; Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester MA, USA.<br /><searchLink fieldCode="AU" term="%22Shumate+L%22">Shumate L</searchLink>; Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester MA, USA.<br /><searchLink fieldCode="AU" term="%22Racenet+Z%22">Racenet Z</searchLink>; Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester MA, USA.<br /><searchLink fieldCode="AU" term="%22M'Bana+V%22">M'Bana V</searchLink>; Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester MA, USA.<br /><searchLink fieldCode="AU" term="%22Oduor+C%22">Oduor C</searchLink>; Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, USA.<br /><searchLink fieldCode="AU" term="%22Matta+A%22">Matta A</searchLink>; Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester MA, USA.<br /><searchLink fieldCode="AU" term="%22Melo+J%22">Melo J</searchLink>; Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester MA, USA.<br /><searchLink fieldCode="AU" term="%22Oluoch+PO%22">Oluoch PO</searchLink>; Department of Microbiology, University of Massachusetts Chan Medical School, Worcester MA, USA.<br /><searchLink fieldCode="AU" term="%22Odwar+B%22">Odwar B</searchLink>; Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.<br /><searchLink fieldCode="AU" term="%22Otieno+J%22">Otieno J</searchLink>; Jaramogi Oginga Odinga Teaching and Referral Hospital, Kisumu, Kenya.<br /><searchLink fieldCode="AU" term="%22Vik+TA%22">Vik TA</searchLink>; Department of Pediatrics, Hematology/Oncology, Indiana University School of Medicine, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22N'juguna+F%22">N'juguna F</searchLink>; Department of Child Health and Paediatrics, Moi University, Eldoret, Kenya.<br /><searchLink fieldCode="AU" term="%22Kinyua+AW%22">Kinyua AW</searchLink>; Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.<br /><searchLink fieldCode="AU" term="%22Bailey+JA%22">Bailey JA</searchLink>; Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, USA.<br /><searchLink fieldCode="AU" term="%22Münz+C%22">Münz C</searchLink>; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Moormann+AM%22">Moormann AM</searchLink>; Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester MA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101680187%22">BioRxiv : the preprint server for biology</searchLink> [bioRxiv] 2026 Feb 10. <i>Date of Electronic Publication: </i>2026 Feb 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Preprint – Name: TitleSource Label: Journal Info Group: Src Data: <i>Country of Publication: </i>United States <i>NLM ID: </i>101680187 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2692-8205 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226928205%22">26928205 </searchLink><i>NLM ISO Abbreviation: </i>bioRxiv <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41727163 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.64898/2026.02.09.704808 Languages: – Code: eng Text: English Titles: – TitleFull: EBV Type 1 versus Type 2: A determinant of NK cell anti-tumor activity in Burkitt lymphoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Forconi CS – PersonEntity: Name: NameFull: Shumate L – PersonEntity: Name: NameFull: Racenet Z – PersonEntity: Name: NameFull: M'Bana V – PersonEntity: Name: NameFull: Oduor C – PersonEntity: Name: NameFull: Matta A – PersonEntity: Name: NameFull: Melo J – PersonEntity: Name: NameFull: Oluoch PO – PersonEntity: Name: NameFull: Odwar B – PersonEntity: Name: NameFull: Otieno J – PersonEntity: Name: NameFull: Vik TA – PersonEntity: Name: NameFull: N'juguna F – PersonEntity: Name: NameFull: Kinyua AW – PersonEntity: Name: NameFull: Bailey JA – PersonEntity: Name: NameFull: Münz C – PersonEntity: Name: NameFull: Moormann AM IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 02 Text: 2026 Feb 10 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2692-8205 Titles: – TitleFull: BioRxiv : the preprint server for biology Type: main |
| ResultId | 1 |